Charles River Laboratories | CRL - Ordinary Share Capital


Charles River Laboratories reported $49.22M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
Agilent USD 283.05M 540K Sep/2025
Align Technology USD 71.75M 736K Dec/2025
Bio-Rad Laboratories USD 26.97M 90K Sep/2025
Bruker USD 151.94M 225K Dec/2025
Cardinal Health USD 238M 1000K Sep/2025
Charles River Laboratories USD 49.22M 2K Dec/2025
Cigna USD 263.46M 3.14M Dec/2025
Concord Medical Services Hldg CNY 105K 0 Jun/2023
CVS Health USD 1.27B 1000K Dec/2025
Danaher USD 706.9M 600K Dec/2025
Dentsply International USD 199.5M 196.5M Sep/2025
Elevance Health USD 222.24M 2.94M Dec/2025
Galapagos EUR 65.9M 0 Sep/2025
Hologic USD 222.57M 350K Sep/2025
Humana USD 120.59M 318K Dec/2025
Illumina USD 152.8M 900K Dec/2025
Incyte USD 198.46M 2.33M Dec/2025
Intrexon USD 0 0 Jun/2024
IQVIA Holdings USD 169.6M 700K Dec/2025
Laboratory Of America USD 82.2M 700K Dec/2025
Lonza CHF 72M 0 Dec/2024
McKesson USD 280M 156M Dec/2025
Merck EUR 434.78M 130.22M Jun/2025
Mettler Toledo International USD 20.43M 170.6K Dec/2025
Novartis USD 1.94B 23.4M Jun/2025
Pfizer USD 5.69B 1000K Sep/2025
Quest Diagnostics USD 110M 1000K Dec/2025
Revvity USD 113.38M 2.7M Dec/2025
Thermo Fisher Scientific USD 375.71M 1.9M Dec/2025
United Therapeutics USD 42.9M 42.1M Sep/2025
UnitedHealth USD 905.84M 161K Dec/2025
Veradigm USD 2.79M 4K Sep/2022
Waters USD 98.08M 38.55M Dec/2025
West Pharmaceutical Services USD 72M 100K Dec/2025